TFC Financial Management’s Idexx Laboratories IDXX Stock Holding History

TFC Financial Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.05K	Buy	2 +1	+100%	+$561	﹤0.01%	644
2026 Q1	$562	Hold	1	–	–	﹤0.01%	689
2025 Q4	$677	Hold	1	–	–	﹤0.01%	655
2025 Q3	$639	Hold	1	–	–	﹤0.01%	680
2025 Q2	$537	Sell	1 -2	-67%	-$956	﹤0.01%	662
2025 Q1	$1.26K	Sell	3 -19	-86%	-$8.25K	﹤0.01%	533
2024 Q4	$9.1K	Sell	22 -1	-4%	-$439	﹤0.01%	362
2024 Q3	$11.6K	Hold	23	–	–	﹤0.01%	358
2024 Q2	$11.2K	Hold	23	–	–	﹤0.01%	334
2024 Q1	$12.4K	Buy	23 +1	+5%	+$546	﹤0.01%	322
2023 Q4	$12.2K	Buy	22 +1	+5%	+$469	﹤0.01%	319
2023 Q3	$9.18K	Hold	21	–	–	﹤0.01%	350
2023 Q2	$10.5K	Buy	21 +1	+5%	+$479	﹤0.01%	330
2023 Q1	$10K	Hold	20	–	–	﹤0.01%	373
2022 Q4	$8.16K	Hold	20	–	–	﹤0.01%	310
2022 Q3	$7K	Hold	20	–	–	﹤0.01%	340
2022 Q2	$7K	Hold	20	–	–	﹤0.01%	328
2022 Q1	$11K	Hold	20	–	–	﹤0.01%	310
2021 Q4	$13K	Hold	20	–	–	﹤0.01%	315
2021 Q3	$12K	Hold	20	–	–	﹤0.01%	318
2021 Q2	$13K	Hold	20	–	–	﹤0.01%	300
2021 Q1	$10K	Hold	20	–	–	﹤0.01%	308
2020 Q4	$10K	Hold	20	–	–	﹤0.01%	312
2020 Q3	$8K	Buy	+20	New	+$7.39K	﹤0.01%	312

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

TFC Financial Management's IDXX Position: Q2 2026 in Review

TFC Financial Management increased its Idexx Laboratories (IDXX) stake by 100% in Q2 2026, buying an estimated $561 and bringing the position to 2 shares worth $1.05K. The position accounts for ﹤0.01% of the portfolio, ranked #644.

TFC Financial Management first reported a position in IDXX in Q3 2020 and has held it in 24 quarters since. The position peaked at $13K in Q4 2021. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

TFC Financial Management held 2 shares of Idexx Laboratories worth $1.05K as of Q2 2026.
TFC Financial Management bought 1 Idexx Laboratories share in Q2 2026, an estimated $561.
Idexx Laboratories made up ﹤0.01% of TFC Financial Management's portfolio in Q2 2026, its #644 holding.
TFC Financial Management first reported a position in Idexx Laboratories in Q3 2020 and has held it in 24 quarters since.
TFC Financial Management's Idexx Laboratories position peaked at $13K in Q4 2021.
1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on TFC Financial Management's 13F filing for Q2 2026, filed 23 Jul 2026.